@article{JXYM4104,
author = {Michael Pinkawa},
title = {Benefit from local treatment of the primary tumor in patients with metastatic prostate cancer at diagnosis},
journal = {Journal of Xiangya Medicine},
volume = {2},
number = {8},
year = {2017},
keywords = {},
abstract = {Prostate cancer is a frequently diagnosed malignant tumor in older men. The majority is treated with curative intent in a localized stage with either radiotherapy or radical prostatectomy (1). Patients with the diagnosis of metastatic prostate cancer at diagnosis have 5-year survival rates of about 30% (2). Standard first-line treatment is an androgen deprivation therapy (ADT). Initial treatment can also include additional chemotherapy (3).},
issn = {2519-9390}, url = {https://jxym.amegroups.org/article/view/4104}
}